RFP
HAE icon

Root Financial Partners’s Haemonetics HAE Stock Holding History

Root Financial Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.92K Buy
105
+7
+7% +$456 ﹤0.01% 1887
2025
Q4 		$7.86K Buy
98
+81
+476% +$5.44K ﹤0.01% 1604
2025
Q3 		$829 Buy
+17
New +$1.05K ﹤0.01% 2088

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Root Financial Partners's HAE Position: Q1 2026 in Review

Root Financial Partners increased its Haemonetics (HAE) stake by 7.1% in Q1 2026, buying an estimated $456 and bringing the position to 105 shares worth $5.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Root Financial Partners first reported a position in HAE in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.86K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Root Financial Partners held 105 shares of Haemonetics worth $5.92K as of Q1 2026.
  • Root Financial Partners bought 7 Haemonetics shares in Q1 2026, an estimated $456.
  • Haemonetics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #1887 holding.
  • Root Financial Partners first reported a position in Haemonetics in Q3 2025 and has held it in 3 quarters since.
  • Root Financial Partners's Haemonetics position peaked at $7.86K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.